The significant reduction in circulating leptin following 1 to 4 days of nCPAP therapy [87,90] suggests that OSAHS itself may stimulate, at least in part, leptin production independently of obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.